Stage-dependent expression of an angiogenic agent and vascular organization in experimental skin tumor development

Toxicologic Pathology

Volumn 31, Issue 5, 2003, Pages 539-548

  Näyhä, Veera ^a   Laitakari, Jaakko ^a   Stenbäck, Frej ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Angiogenesis; Blood vessels; Mouse skin tumors; Vascular endothelial growth factor (VEGF)

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTIBODIES; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; IMAGE CYTOMETRY; LAMININ; MICE; MICE, INBRED STRAINS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA;

EID: 0141787190     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230309791     Document Type: Article

References (75)

1. Albo D, Granick MS, Jhala N, Atkinson B, Solomon MP (1994). The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck. Ann Plast Surg 32: 588-594.
2. Arbeit JM, Olson DC, Hanahan D (1996). Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice. Oncogene 13: 1847-1857.
3. Bergers G, Hanahan D, Coussens LM (1998). Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis. Int J Dev Biol 42: 995-1002.
4. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D (1999). Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284: 808-812.
5. Bleuel K, Popp S, Fusenig NE, Stanbridge EJ, Boukamp P (1999). Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. Proc Natl Acad Sci USA 96: 2065-2070.
6. Bolontrade MF, Stern MC, Binder RL, Zenklusen JC, Gimenez-Conti IB, Conti CJ (1998). Angiogenesis is an early event in the development of chemically induced skin tumors. Carcinogenesis 19: 2107-2113.
7. Burian M, Quint C, Neuchrist C (1999). Angiogenic factors in laryngeal carcinomas: Do they have prognostic relevance? Acta Otolaryngol 119: 289-292.
8. Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM, Dvorak HF (1997). Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine. EXS 79: 233-269.
9. Brustmann H, Riss P, Naude S (1997). The relevance of angiogenesis in benign and malignant epithelial tumors of the ovary: A quantitative histologic study. Gynecol Oncol 67: 20-26.
10. Carmeliet P, Collen D (2000). Transgenic mouse models in angiogenesis and cardiovascular disease. J Pathol 190: 387-405.
11. Cohen T, Gitay-Goren H, Sharon R, Shibuya M, Halaban R, Levi BZ, Neufeld G (1995). VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 270: 11322-11326.
12. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope, DA, Thomas KA (1990). Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87: 2628-2632.
13. Conn G, Soderman DD, Schaeffer MT, Wile M, Hatcher VB, Thomas KA (1990). Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 87: 1323-1327.
14. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino, JJ, Siegel NR, Leimgruber RM, Feder J (1989). Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478.
15. Conti CJ (2002). Vascular endothelial growth factor: Regulation in the mouse skin carcinogenesis model and use in antiangiogenesis cancer therapy. Oncologist 7(Suppl 3): 4-11.
16. Detmar M (2000). The role of VEGF and thrombospondins in skin angiogenesis. J Dermatol Sci Suppl 1: S78-S84.
17. Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK (1998). Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111: 1-6.
18. Detmar M (1996). Molecular regulation of angiogenesis in the skin. J Invest Dermatol 106: 207-208.
19. Detmar M (2000). Tumor angiogenesis. J Investig Dermatol Symp Proc 5: 20-23.
20. Enholm B, Karpanen T, Jeltsch M, Kubo H, Stenback F, Prevo R, Jackson DG, Ylä-Herttuala S, Alitalo K (2001). Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res 88: 623-636.
21. Ferrara N, Alitalo K (1999). Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5: 1359-1364.
22. Folberg R, Hendrix MJ, Maniotis AJ (2000). Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156: 361-381.
23. Folkman J (1997). Angiogenesis and angiogenesis inhibition: An overview. EXS 79: 1-8.
24. Folkman J (1990). What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6.
25. Folkman J (1996). New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 32A: 2534-2539.
26. Folkman J, Watson K, Ingber D, Hanahan D (1989). Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58-61.
27. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla PP, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F (1994). Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466.
28. Gasparini G (2001). Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. Crit Rev Oncol Hematol 37: 97-114.
29. Goodall CM, Sanders AG, Shubik P (1965). Studies of vascular patterns in living tumors with a transparent chamber inserted in hamster cheek pouch. J Natl Cancer Inst 35: 497-521.
30. Gorstein F (1988). The dynamic extracellular matrix. Hum Pathol 19: 751-752.
31. Guidi AJ, Abu-Jawdeh G, Berse B, Jackman RW, Tognazzi K, Dvorak HF, Brown LF (1995). Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 87: 1237-1245.
32. Hanahan D, Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
33. Hanahan D, Christofori G, Naik P, Arbeit J (1996). Transgenic mouse models of tumour angiogenesis: The angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur J Cancer 32A: 2386-2393.
34. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D (1991). Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66: 1095-1104.
35. Kuwano H, Sonoda K, Yasuda M, Sumiyoshi K, Nozoe T, Sugimachi K (1997). Tumor invasion and angiogenesis in early esophageal squamous cell carcinoma. J Surg Oncol 65: 188-193.
36. Laitakari J, Stenback F (2001). Morphometrical characteristics of cell proliferation and p53 expression in development of experimentally induced respiratory tumors. Analyt Quant Cytol Histol 23: 273-286.
37. Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL (1996). Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res 56: 5391-5396.
38. Leedy DA, Trune DR, Kronz JD, Weidner N, Cohen JI (1994). Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue. Otolaryngol Head Neck Surg 111: 417-422.
39. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309.
40. Levy AP, Tamargo R, Brem H, Nathans D (1989). An endothelial cell growth factor from the mouse neuroblastoma cell line NB41. Growth Factors 2: 9-19.
41. Li CY, Shan S, Huang Q, Braun RD, Lanzen J, Hu K, Lin P, Dewhirst MW (2000). Initial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent models. J Natl Cancer Inst 92: 143-147.
42. Liotta LA, Abe S, Robey PG, Martin GR (1979). Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc Natl Acad Sci USA 76: 2268-2272.
43. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA (1992). Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340: 145-146.
44. Macchiarini P, Fontanini G, Hardin JM, Pingitore R, Angeletti CA (1992). Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone. J Thorac Cardiovasc Surg 104: 892-899.
45. Mäkinen M, Stenbäck F (1998). Skin tumor development and keratin expression in different experimental models. Relation to inducing agent and target tissue structure. Exp Toxicol Pathol 50: 199-208.
46. Mäkinen M, Jussila T, Stenbäck F (1998). Epidermal cell adhesion and basement membrane alterations in experimental skin tumour development. Anticancer Res 18: 877-884.
47. Meiron M, Anunu R, Scheinman EJ, Hashmueli S, Levi BZ (2001). New isoforms of VEGF are translated from alternative initiation CUG codons located in its 5′UTR. Biochem Biophys Res Commun 282: 1053-1060.
48. Mineta H, Miura K, Ogino T, Takebayashi S, Misawa K, Ueda Y, Suzuki I, Dictor M, Borg A, Wennerberg J (2000). Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer 83: 775-781.
49. Moriyama M, Kumagai S, Kawashiri S, Kojima K, Kakihara K, Yamamoto E (1997). Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol 33: 369-374.
50. Neuchrist C, Quint C, Pammer A, Burian M (1999). Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: An immunohistochemical study. Acta Otolaryngol 119: 732-738.
51. Plate KH, Breier G, Weich HA, Risau W (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848.
52. Plouet J, Schilling J, Gospodarowicz D(1989). Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 8: 3801-3806.
53. Pozzi A, Moberg PE, Miles LA, Wagner S, Soloway P, Gardner HA (2000). Elevated matrix metalloprotease and angiostatin levels in integrin α1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci USA 97: 2202-2207.
54. Risau W (1990). Angiogenic growth factors. Progr Growth Factor Res 2(1): 71-79.
55. Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M (1999). Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 5: 775-782.
56. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985.
57. Skobe M, Rockwell P, Goldstein N, Vosseler S, Fusenig NE (1997). Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 3: 1222-1227.
58. Smith-McCune K, Zhu YH, Hanahan D, Arbeit J (1997). Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res 57: 1294-1300.
59. Smith-McCune KK, Weidner N (1994). Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 54: 800-804.
60. Stenbäck F, Mäkinen M, Jussila T (1998). p53 expression in skin carcinogenesis: Relation to cell proliferation and tumour growth. Eur J Cancer 34: 1415-1424.
61. Stenbäck F (1978). Life history and histopathology of ultraviolet light-induced skin tumors. Natl Cancer Inst Monogr 50: 57-70.
62. Stenbäck F, Mäkinen M, Jussila T, Kauppila S, Risteli J, Talve L, Risteli L (1999). The extracellular matrix in skin tumor development - A morphological study. J Cutan Path 26: 327-338.
63. Strieth S, Hartschuh W, Pilz L, Fusenig NE (2000). Angiogenic switch occurs late in squamous cell carcinomas of human skin. Br J Cancer 82: 591-600.
64. Tae K, El-Naggar AK, Yoo E, Feng L, Lee JJ, Hong WK, Hittelman WN, Shin DM (2000). Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. Clin Cancer Res 6: 2821-2828.
65. Ushmorov AG, Furstenberger G, Faissner A, Marks F (1994). Effects of complete and incomplete tumor promoters on hair growth, angiogenesis, and tenascin expression in the skin of NMRI mice. Carcinogenesis 15: 2739-2745.
66. Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, Pihlajaniemi T, Weich H, deWaal R, Alitalo K (1999). VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154: 1381-1390.
67. Warren BA (1966). The ultrastructure of capillary sprouts induced by melanoma transplants in the golden hamster. J Royal Microscop Soc 86: 177-187.
68. Warren BA, Shubik P (1966). The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab Invest 15: 464-478.
69. Weidner N (1993). Tumor angiogenesis: Review of current applications in tumor prognostication. Semin Diagn Pathol 10: 302-313.
70. Weidner N (2000). Angiogenesis as a predictor of clinical outcome in cancer patients. Hum Pathol 31: 403-405.
71. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J (1993). Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409.
72. Weidner N, Folkman J (1996). Tumor vascularity as a prognostic factor in breast cancer. Import Adv Oncol 167-190.
73. Weidner N, Semple JP, Welch WR, Folkman J (1991). Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8.
74. Weninger W, Uthman A, Pammer J, Pichler A, Ballaun C, Lang IM, Plettenberg A, Bankl HC, Sturzl M, Tschachler E (1996). Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab Invest 75: 647-657.
75. Zhang HT, Scott PA, Morbidelli L, Peak S, Moore J, Turley H, Harris AL, Ziche M, Bicknell R (2000). The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer 83: 63-68.